{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:40:29Z","timestamp":1783723229883,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,4,22]],"date-time":"2007-04-22T00:00:00Z","timestamp":1177200000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1038\/ng2030","type":"journal-article","created":{"date-parts":[[2007,4,22]],"date-time":"2007-04-22T13:17:16Z","timestamp":1177247836000},"page":"605-613","source":"Crossref","is-referenced-by-count":226,"title":["A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers"],"prefix":"10.1038","volume":"39","author":[{"given":"Tong","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuankai","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingrun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,4,22]]},"reference":[{"key":"BFng2030_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc1782","volume":"6","author":"KE de Visser","year":"2006","unstructured":"de Visser, K.E., Eichten, A. & Coussens, L.M. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 6, 24\u201337 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"BFng2030_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1034\/j.1600-065X.2003.00051.x","volume":"193","author":"DR Green","year":"2003","unstructured":"Green, D.R., Droin, N. & Pinkoski, M. Activation-induced cell death in T cells. Immunol. Rev. 193, 70\u201381 (2003).","journal-title":"Immunol. Rev."},{"key":"BFng2030_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s002620050505","volume":"47","author":"DB Chappell","year":"1998","unstructured":"Chappell, D.B. & Restifo, N.P. T cell-tumor cell: a fatal interaction? Cancer Immunol. Immunother. 47, 65\u201371 (1998).","journal-title":"Cancer Immunol. Immunother."},{"key":"BFng2030_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1440-1711.2002.01068.x","volume":"80","author":"S Maher","year":"2002","unstructured":"Maher, S., Toomey, D., Condron, C. & Bouchier-Hayes, D. Activation-induced cell death: the controversial role of FAS and FAS ligand in immune privilege and tumor counterattack. Immunol. Cell Biol. 80, 131\u2013137 (2002).","journal-title":"Immunol. Cell Biol."},{"key":"BFng2030_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/labinvest.3700389","volume":"86","author":"P Yu","year":"2006","unstructured":"Yu, P. & Fu, Y.X. Tumor-infiltrating T lymphocytes: friends or foes? Lab. Invest. 86, 231\u2013245 (2006).","journal-title":"Lab. Invest."},{"key":"BFng2030_CR6","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nri1184","volume":"3","author":"BB Aggarwal","year":"2003","unstructured":"Aggarwal, B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3, 745\u2013756 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"BFng2030_CR7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nri1809","volume":"6","author":"RM Siegel","year":"2006","unstructured":"Siegel, R.M. Caspases at the crossroads of immune-cell life and death. Nat. Rev. Immunol. 6, 308\u2013317 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"BFng2030_CR8","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1111\/j.1742-4658.2005.04966.x","volume":"272","author":"PK Ho","year":"2005","unstructured":"Ho, P.K. & Hawkins, C.J. Mammalian initiator apoptotic caspases. FEBS J. 272, 5436\u20135453 (2005).","journal-title":"FEBS J."},{"key":"BFng2030_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cellsig.2003.08.007","volume":"16","author":"A Thorburn","year":"2004","unstructured":"Thorburn, A. Death receptor-induced cell killing. Cell. Signal. 16, 139\u2013144 (2004).","journal-title":"Cell. Signal."},{"key":"BFng2030_CR10","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1093\/jnci\/djh187","volume":"96","author":"T Sun","year":"2004","unstructured":"Sun, T. et al. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J. Natl. Cancer Inst. 96, 1030\u20131036 (2004).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFng2030_CR11","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1084\/jem.20050707","volume":"202","author":"T Sun","year":"2005","unstructured":"Sun, T. et al. FASL-844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. J. Exp. Med. 202, 967\u2013974 (2005).","journal-title":"J. Exp. Med."},{"key":"BFng2030_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1136\/jmg.2004.030106","volume":"42","author":"X Zhang","year":"2005","unstructured":"Zhang, X. et al. Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. J. Med. Genet. 42, 479\u2013484 (2005).","journal-title":"J. Med. Genet."},{"key":"BFng2030_CR13","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/jnci\/djh289","volume":"96","author":"P Krippl","year":"2004","unstructured":"Krippl, P., Langsenlehner, U., Renner, W., Koppel, H. & Samonigg, H. Re: Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J. Natl. Cancer Inst. 96, 1478\u20131479 (2004).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFng2030_CR14","first-page":"4327","volume":"63","author":"K Sibley","year":"2003","unstructured":"Sibley, K. et al. Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res. 63, 4327\u20134330 (2003).","journal-title":"Cancer Res."},{"key":"BFng2030_CR15","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1093\/jnci\/dji001","volume":"96","author":"G MacPherson","year":"2004","unstructured":"MacPherson, G. et al. Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J. Natl. Cancer Inst. 96, 1866\u20131869 (2004).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFng2030_CR16","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/jnci\/dji178","volume":"97","author":"B Frank","year":"2005","unstructured":"Frank, B. et al. Re: Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J. Natl. Cancer Inst. 97, 1012 (2005).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFng2030_CR17","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/carcin\/bgi248","volume":"27","author":"B Frank","year":"2006","unstructured":"Frank, B. et al. Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis 27, 606\u2013609 (2006).","journal-title":"Carcinogenesis"},{"key":"BFng2030_CR18","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ng1981","volume":"39","author":"A Cox","year":"2007","unstructured":"Cox, A. et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat. Genet. 39, 352\u2013358 (2007).","journal-title":"Nat. Genet."},{"key":"BFng2030_CR19","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1126\/science.312.5777.1131","volume":"312","author":"J Couzin","year":"2006","unstructured":"Couzin, J. Genomics. The HapMap gold rush: researchers mine a rich deposit. Science 312, 1131 (2006).","journal-title":"Science"},{"key":"BFng2030_CR20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.cell.2004.11.022","volume":"119","author":"GL Bond","year":"2004","unstructured":"Bond, G.L. et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119, 591\u2013602 (2004).","journal-title":"Cell"},{"key":"BFng2030_CR21","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1093\/emboj\/16.10.2794","volume":"16","author":"JP Medema","year":"1997","unstructured":"Medema, J.P. et al. FLICE is activated by association with the CD95 death-inducing signaling complex (Drosoph. Inf. Serv.C). EMBO J. 16, 2794\u20132804 (1997).","journal-title":"EMBO J."},{"key":"BFng2030_CR22","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0092-8674(00)81265-9","volume":"85","author":"MP Boldin","year":"1996","unstructured":"Boldin, M.P., Goncharov, T.M., Goltsev, Y.V. & Wallach, D. Involvement of MACH, a novel MORT1\/FADD-interacting protease, in Fas\/APO-1- and TNF receptor-induced cell death. Cell 85, 803\u2013815 (1996).","journal-title":"Cell"},{"key":"BFng2030_CR23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0092-8674(00)81266-0","volume":"85","author":"M Muzio","year":"1996","unstructured":"Muzio, M. et al. FLICE, a novel FADD-homologous ICE\/CED-3-like protease, is recruited to the CD95 (Fas\/APO-1) death\u2013inducing signaling complex. Cell 85, 817\u2013827 (1996).","journal-title":"Cell"},{"key":"BFng2030_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/75007","volume":"6","author":"T Teitz","year":"2000","unstructured":"Teitz, T. et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat. Med. 6, 529\u2013535 (2000).","journal-title":"Nat. Med."},{"key":"BFng2030_CR25","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1158\/0008-5472.815.65.3","volume":"65","author":"YH Soung","year":"2005","unstructured":"Soung, Y.H. et al. CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res. 65, 815\u2013821 (2005).","journal-title":"Cancer Res."},{"key":"BFng2030_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/sj.onc.1208244","volume":"24","author":"YH Soung","year":"2005","unstructured":"Soung, Y.H. et al. Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas. Oncogene 24, 141\u2013147 (2005).","journal-title":"Oncogene"},{"key":"BFng2030_CR27","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S0016-5085(03)01059-X","volume":"125","author":"HS Kim","year":"2003","unstructured":"Kim, H.S. et al. Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 125, 708\u2013715 (2003).","journal-title":"Gastroenterology"},{"key":"BFng2030_CR28","doi-asserted-by":"publisher","first-page":"27593","DOI":"10.1074\/jbc.M304077200","volume":"278","author":"C Liedtke","year":"2003","unstructured":"Liedtke, C., Groger, N., Manns, M.P. & Trautwein, C. The human caspase-8 promoter sustains basal activity through SP1 and ETS-like transcription factors and can be up-regulated by a p53-dependent mechanism. J. Biol. Chem. 278, 27593\u201327604 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFng2030_CR29","doi-asserted-by":"publisher","first-page":"26953","DOI":"10.1074\/jbc.272.43.26953","volume":"272","author":"C Scaffidi","year":"1997","unstructured":"Scaffidi, C., Medema, J.P., Krammer, P.H. & Peter, M.E. FLICE is predominantly expressed as two functionally active isoforms, caspase-8\/a and caspase-8\/b. J. Biol. Chem. 272, 26953\u201326958 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFng2030_CR30","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1073\/pnas.072088099","volume":"99","author":"DG Breckenridge","year":"2002","unstructured":"Breckenridge, D.G., Nguyen, M., Kuppig, S., Reth, M. & Shore, G.C. The procaspase-8 isoform, procaspase-8L, recruited to the BAP31 complex at the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 99, 4331\u20134336 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng2030_CR31","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1182\/blood.V99.11.4070","volume":"99","author":"D Himeji","year":"2002","unstructured":"Himeji, D. et al. Characterization of caspase-8L: a novel isoform of caspase-8 that behaves as an inhibitor of the caspase cascade. Blood 99, 4070\u20134078 (2002).","journal-title":"Blood"},{"key":"BFng2030_CR32","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/373444a0","volume":"373","author":"ST Ju","year":"1995","unstructured":"Ju, S.T. et al. FAS (CD95)\/FASL interactions required for programmed cell death after T-cell activation. Nature 373, 444\u2013448 (1995).","journal-title":"Nature"},{"key":"BFng2030_CR33","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/35077213","volume":"411","author":"GI Evan","year":"2001","unstructured":"Evan, G.I. & Vousden, K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342\u2013348 (2001).","journal-title":"Nature"},{"key":"BFng2030_CR34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/carcin\/21.3.485","volume":"21","author":"SW Lowe","year":"2000","unstructured":"Lowe, S.W. & Lin, A.W. Apoptosis in cancer. Carcinogenesis 21, 485\u2013495 (2000).","journal-title":"Carcinogenesis"},{"key":"BFng2030_CR35","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1038\/sj.onc.1202769","volume":"18","author":"SH Lee","year":"1999","unstructured":"Lee, S.H. et al. Alteration of Fas (APO-1\/CD95) gene in non-small cell lung cancer. Oncogene 18, 3754\u20133760 (1999).","journal-title":"Oncogene"},{"key":"BFng2030_CR36","first-page":"2057","volume":"58","author":"C Gratas","year":"1998","unstructured":"Gratas, C. et al. Up-regulation of Fas (APO-1\/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Res. 58, 2057\u20132062 (1998).","journal-title":"Cancer Res."},{"key":"BFng2030_CR37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ygyno.2004.10.046","volume":"96","author":"N Reesink-Peters","year":"2005","unstructured":"Reesink-Peters, N. et al. Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study. Gynecol. Oncol. 96, 705\u2013713 (2005).","journal-title":"Gynecol. Oncol."},{"key":"BFng2030_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1023\/A:1006102601215","volume":"54","author":"LS Gutierrez","year":"1999","unstructured":"Gutierrez, L.S., Eliza, M., Niven-Fairchild, T., Naftolin, F. & Mor, G. The Fas\/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas. Breast Cancer Res. Treat. 54, 245\u2013253 (1999).","journal-title":"Breast Cancer Res. Treat."},{"key":"BFng2030_CR39","first-page":"4942","volume":"61","author":"MS Shin","year":"2001","unstructured":"Shin, M.S. et al. Mutation of tumor necrosis factor-related apoptosis-inducing ligand receptor 1(TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers. Cancer Res. 61, 4942\u20134946 (2001).","journal-title":"Cancer Res."},{"key":"BFng2030_CR40","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1053\/gast.2001.28663","volume":"121","author":"WS Park","year":"2001","unstructured":"Park, W.S. et al. Inactivating mutations of KILLER\/DR5 gene in gastric cancers. Gastroenterology 121, 1219\u20131225 (2001).","journal-title":"Gastroenterology"},{"key":"BFng2030_CR41","first-page":"291","volume":"20","author":"C Kase","year":"2002","unstructured":"Kase, C. et al. Expression of Fas and Fas ligand in esophageal tissue mucosa and carcinomas. Int. J. Oncol. 20, 291\u2013297 (2002).","journal-title":"Int. J. Oncol."},{"key":"BFng2030_CR42","first-page":"565","volume":"129","author":"X Zhang","year":"2005","unstructured":"Zhang, X. et al. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129, 565\u2013576 (2005).","journal-title":"Gastroenterology"},{"key":"BFng2030_CR43","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1053\/j.gastro.2006.03.021","volume":"130","author":"F Liu","year":"2006","unstructured":"Liu, F. et al. Genetic variants in cyclooxygenase-2: expression and risk of gastric cancer and its precursors in a Chinese population. Gastroenterology 130, 1975\u20131984 (2006).","journal-title":"Gastroenterology"},{"key":"BFng2030_CR44","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1093\/carcin\/bgh244","volume":"25","author":"T Sun","year":"2004","unstructured":"Sun, T. et al. Functional Phe31Ile polymorphism in Aurora A and risk of breast carcinoma. Carcinogenesis 25, 2225\u20132230 (2004).","journal-title":"Carcinogenesis"},{"key":"BFng2030_CR45","volume-title":"Carcinogenesis","author":"W Tan","year":"2006","unstructured":"Tan, W. et al. Association of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer. Carcinogenesis published online 6 December 2006 (doi:10.1093\/carcin\/bgl242)."},{"key":"BFng2030_CR46","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature02623","volume":"429","author":"CS Carlson","year":"2004","unstructured":"Carlson, C.S., Eberle, M.A., Kruglyak, L. & Nickerson, D.A. Mapping complex disease loci in whole-genome association studies. Nature 429, 446\u2013452 (2004).","journal-title":"Nature"},{"key":"BFng2030_CR47","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1073\/pnas.98.2.581","volume":"98","author":"KH Buetow","year":"2001","unstructured":"Buetow, K.H. et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry. Proc. Natl. Acad. Sci. USA 98, 581\u2013584 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng2030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng2030","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng2030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T10:19:40Z","timestamp":1707819580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng2030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,22]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["BFng2030"],"URL":"https:\/\/doi.org\/10.1038\/ng2030","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1088193.541208","asserted-by":"object"}]},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,22]]}}}